Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection
- PMID: 32406512
- PMCID: PMC7239115
- DOI: 10.1093/jtm/taaa069
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers are not associated with increased risk of SARS-CoV-2 infection
Abstract
In a large Israeli dataset of 14 520 individuals tested for SARS-CoV-2, angiotension-converting enzyme inhibitors and angiotensin-receptor blockers were not found to be associated with increased SARS-CoV-2 infection after adjusting for major confounders. Patients on these medications should not stop their medication prophylactically.
Keywords: ACE2 receptor; BMI; Covid19; Israel; Vitamin D; anti-hypertensive; body mass index; hypertension; obesity.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
